The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180: 5653-5661.
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Al-Sadi, R.
Right arrow Articles by Ma, T. Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Sadi, R.
Right arrow Articles by Ma, T. Y.

Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability1

Rana Al-Sadi*, Dongmei Ye*, Karol Dokladny* and Thomas Y. Ma2,*,{dagger}

* Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; and {dagger} Albuquerque Veterans Affairs Medical Center, Albuquerque, NM 87108

The IL-1β-induced increase in intestinal epithelial tight junction (TJ) permeability has been postulated to be an important mechanism contributing to intestinal inflammation of Crohn’s disease and other inflammatory conditions of the gut. The intracellular and molecular mechanisms that mediate the IL-1β-induced increase in intestinal TJ permeability remain unclear. The purpose of this study was to elucidate the mechanisms that mediate the IL-1β-induced increase in intestinal TJ permeability. Specifically, the role of myosin L chain kinase (MLCK) was investigated. IL-1β caused a progressive increase in MLCK protein expression. The time course of IL-1β-induced increase in MLCK level correlated linearly with increase in Caco-2 TJ permeability. Inhibition of the IL-1β-induced increase in MLCK protein expression prevented the increase in Caco-2 TJ permeability. Inhibition of the IL-1β-induced increase in MLCK activity also prevented the increase in Caco-2 TJ permeability. Additionally, knock-down of MLCK protein expression by small interference RNA prevented the IL-1β-induced increase in Caco-2 TJ permeability. The IL-1β-induced increase in MLCK protein expression was preceded by an increase in MLCK mRNA expression. The IL-1β-induced increase in MLCK mRNA transcription and subsequent increase in MLCK protein expression and Caco-2 TJ permeability was mediated by activation of NF-{kappa}B. In conclusion, our data indicate that the IL-1β increase in Caco-2 TJ permeability was mediated by an increase in MLCK expression and activity. Our findings also indicate that the IL-1β-induced increase in MLCK protein expression and Caco-2 TJ permeability was mediated by an NF-{kappa}B-dependent increase in MLCK gene transcription.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This research project was supported by a Veterans Affairs Merit Review grant from the Veterans Affairs Research Service and National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-64165-01 (to T.Y.M.).

2 Address correspondence and reprint requests to Dr. Thomas Y. Ma, Internal Medicine-Gastroenterology, Mail Stop Code 10 5550, University of New Mexico, Albuquerque, NM 87131. E-mail address: tma{at}salud.unm.edu

3 Abbreviations used in this paper: TJ, tight junction; CD, Crohn’s disease; siRNA, small interference RNA; MLCK, that myosin light chain kinase; TER, transepithelial electrical resistance.


Related articles in The JI:

IN THIS ISSUE

The JI 2008 180: 5155-5156. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.